Jerrold D. Dotson
Overview
Jerrold D. Dotson received an average of $608K in total compensation, including $342K in salary, at Vistagen Therapeutics from 2015 to 2023.
2023Vistagen TherapeuticsChief Financial Officer
2022Vistagen TherapeuticsChief Financial Officer
2020Vistagen TherapeuticsVice President, Chief Financial Officer and Secretary
2019Vistagen TherapeuticsVice President, Chief Financial Officer and Secretary
2016Vistagen TherapeuticsVice President, Chief Financial Officer, Secretary
2015Vistagen TherapeuticsVice President, Chief Financial Officer, Secretary
Source: SEC filings on July 28, 2023, July 27, 2020, and August 5, 2016.
Related executives
We found seven more executives who work or worked at Vistagen Therapeutics.
Shawn Singh
Vistagen Therapeutics
Chief Executive Officer
Reid Adler
Vistagen Therapeutics
General Counsel
Joshua Prince
Vistagen Therapeutics
Chief Operating Officer
Cynthia Anderson
Vistagen Therapeutics
Chief Financial Officer
H Snodgrass
Vistagen Therapeutics
Chief Scientific Officer
Mark Smith
Vistagen Therapeutics
Chief Medical Officer
Mark McPartland
Vistagen Therapeutics